Cargando…
Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole
BACKGROUND: If left untreated, vitreomacular traction (VMT) will infrequently improve through spontaneous resolution of vitreomacular adhesion (VMA), and patients remain at risk of further deterioration in vision. The mainstay of treatment for VMT is vitrectomy, an invasive procedure that carries th...
Autores principales: | Bennison, Craig, Stephens, Stephanie, Lescrauwaet, Benedicte, Van Hout, Ben, Jackson, Timothy L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Co-Action Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920942/ https://www.ncbi.nlm.nih.gov/pubmed/27429719 http://dx.doi.org/10.3402/jmahp.v4.31472 |
Ejemplares similares
-
Visual function response to ocriplasmin for the treatment of vitreomacular traction and macular hole
por: Jackson, Timothy L., et al.
Publicado: (2017) -
Patient-reported outcomes of ocriplasmin for the treatment of vitreomacular traction: a systematic review and synthesis of the literature
por: Lescrauwaet, Benedicte, et al.
Publicado: (2019) -
Ocriplasmin for Treatment of Vitreomacular Traction: An Update
por: Khan, Mohammed Ali, et al.
Publicado: (2016) -
Effect of Funding Source on “Spin” in Studies of Ocriplasmin Therapy for Vitreomacular Traction and Macular Hole
por: Hubschman, Sasha, et al.
Publicado: (2020) -
Intravitreal ocriplasmin for the treatment of vitreomacular traction and macular hole- A study of efficacy and safety based on NICE guidance
por: Muqit, Mahiul M. K., et al.
Publicado: (2018)